• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Drug Marketing: Different Impacts on Different Physicians

by Marlene Piturro, PhD, MBA • December 1, 2006

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

The American Medical Association, responding to its members’ concerns about the increasingly sophisticated information culled by PCRs from databases on individual physician prescribing patterns, introduced new procedures in July 2006 to give doctors some control over data access. Through the Prescribing Data Restriction Program (PDRP), individual physicians who enroll can stop PCRs and their direct supervisors from having access to their prescribing patterns. However, such data will still be available to pharmaceutical companies for marketing, compensation, and research. For starters, the PDRP allows the pharmaceutical industry to police itself. Physicians can also contact their state legislatures to sound the alarms.

You Might Also Like

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • AMA’s Opt-Out Provision for Sale of Physician Prescribing Data Seen as First Step
  • Prescription Drug Benefit Primer
  • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing
Explore This Issue
December 2006

Despite the pharmaceutical industry’s unwavering focus on getting physicians to prescribe their products at the highest possible levels, and the doctors’ need to keep them at arm’s length, the two groups are linked. Dr. Krouse points out that the pharmaceutical industry has “cleaned up its act in the last few years, doing away with inappropriate gifts and other egregious lapses.” The industry recently funded 13 unrestricted grants for American Academy of Otolaryngic Allergy medical residents, allowing young physicians to explore academic medicine. Continually refining the relationship between the drug industry and physicians to keep it mutually beneficial is an ongoing challenge.

Teaching Medical Students to Handle PCRs

To help third-year medical students become aware of PCR influence on physician prescribing habits and professional behavior, professors at Wake Forest University teach a mandatory course for these students and other physicians covering:

  • Typical physician–PCR interactions
  • Appropriate uses of samples and gifts
  • Validity and legal boundaries of PCR information
  • Ethics
  • Role plays

Prior to the course, 57% of the students were unaware that guidelines regarding interactions with PCRs exist, and 28% thought that there should be no restrictions on gifts including lunches, stethoscopes, textbooks, educational CD-ROMs, and sporting events.

At the course’s conclusion, both practicing physicians and students said they knew more about dealing with PCRs. Students surveyed indicated increased understanding of PCR–MD interactions, from 17.7% before the course to 43.2% after. For practicing physicians, 40.5% said they better understand such interactions after the course, whereas only 22.1% said so pre-course.

Source: Wofford JL, Ohi CA. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Educ 2005 Feb 8;5(1):5.

©2006 The Triological Society

Pages: 1 2 3 | Single Page

Filed Under: Departments, Everyday Ethics, Health Policy, Medical Education, Practice Management Tagged With: Ethics, healthcare reform, marketing, medical education, medication, pharmaceuticals, policy, residentsIssue: December 2006

You Might Also Like:

  • When It Comes to Drug Development, What Do Our Dollars Buy?
  • AMA’s Opt-Out Provision for Sale of Physician Prescribing Data Seen as First Step
  • Prescription Drug Benefit Primer
  • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • Excitement Around Gene Therapy for Hearing Restoration

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939